home / stock / azn / azn articles

AZN Articles, AstraZeneca PLC - From 06/17/24

Stock Information
Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NYSE
Website: astrazeneca.com
Menu
AZN AZN Quote AZN Short AZN News AZN Articles AZN Message Board
Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday? | Benzinga

Sunday, Nurix Therapeutics Inc (NASDAQ:NRIX) announced the presentation of updated clinical data for NX-5948, an orally bioavailable degrader of Br...
FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer | Benzinga

AstraZeneca plc’s (NASDAQ:AZN) cancer drug, Imfinzi (durvalumab), in conjunction with standard chemotherapy, has now received endorsement fro...

AstraZeneca Says Calquence/Chemo Combo Data Shows Additional 16.8 Months Without Disease Progression In Patients With Certain Type Of Blood Cancer | Benzinga

AstraZeneca Plc (NASDAQ:AZN) released data from the ECHO Phase 3 trial of Calquence (acalabrutinib) plus bendamustine and rituximab compa...

Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails | Benzinga

This week, an FDA advisory committee unanimously recommended approval of Eli Lilly's (NYSE: LLY) Alzheimer's disease drug, donanemab. Pfize...
Here's How Much You Would Have Made Owning AstraZeneca Stock In The Last 5 Years | Benzinga

AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years by 2.26% on an annualized basis producing an average annual return of 15...

Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug | Benzinga

Tuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to AstraZeneca Plc’s (NASDA...

Cellectis Reports Financial Results for First Quarter 2024 | Benzinga

•  Cellectis announced completion of the additional equity investment of $140M by AstraZeneca •  Cash position of $143 million as of March...
Why Is AstraZeneca Stock Trading Lower On Tuesday? | Benzinga

On Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population...

AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report | Benzinga

Western pharmaceutical companies and investors are driving a record number of licensing deals with Chinese drugmakers struggling to fund late-stage...

Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity | Benzinga

On Thursday, Tango Therapeutics Inc. (NASDAQ:TNGX) announced that it will discontinue the development of its TNG348 program. “...
Previous 10 Next 10